Abbott Laboratories shares owned by Weybosset Research & Management
Quarter-by-quarter ownership of Abbott Laboratories (ABT) shares owned by Weybosset Research & Management
from 13F filings
Historical chart of Weybosset Research & Management investment in Abbott Laboratories
Tip: Access up to 7 years of quarterly data
All positions including Abbott Laboratories held by Weybosset Research & Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abbott Laboratories by Weybosset Research & Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $265k | 2.1k | 127.40 |
| 2023-12-31 | $229k | 2.1k | 110.07 |
| 2023-06-30 | $205k | 1.9k | 109.04 |
| 2023-03-31 | $278k | 2.8k | 101.09 |
| 2022-12-31 | $296k | 2.7k | 109.63 |
| 2022-09-30 | $261k | 2.7k | 96.67 |
| 2022-06-30 | $261k | 2.4k | 108.75 |
| 2021-09-30 | $289k | 2.5k | 117.96 |
| 2021-06-30 | $388k | 3.4k | 115.82 |
| 2021-03-31 | $366k | 3.1k | 120.00 |
| 2020-12-31 | $334k | 3.1k | 109.51 |
| 2020-09-30 | $365k | 3.4k | 108.96 |
| 2020-06-30 | $434k | 4.8k | 91.37 |
| 2020-03-31 | $363k | 4.8k | 76.42 |
| 2019-12-31 | $413k | 4.8k | 86.95 |
| 2019-09-30 | $397k | 4.8k | 83.58 |
| 2019-06-30 | $399k | 4.8k | 84.00 |
| 2019-03-31 | $368k | 4.6k | 80.00 |
| 2018-12-31 | $333k | 4.6k | 72.39 |
| 2018-09-30 | $330k | 4.5k | 73.33 |
| 2018-06-30 | $274k | 4.5k | 60.89 |
| 2018-03-31 | $270k | 4.5k | 60.00 |
| 2017-12-31 | $263k | 4.6k | 57.17 |
| 2017-09-30 | $245k | 4.6k | 53.26 |
| 2017-06-30 | $228k | 4.7k | 48.51 |
| 2017-03-31 | $209k | 4.7k | 44.47 |
| 2015-06-30 | $206k | 4.2k | 49.05 |
| 2015-03-31 | $252k | 5.5k | 46.24 |
| 2014-12-31 | $245k | 5.5k | 44.95 |
| 2014-09-30 | $227k | 5.5k | 41.65 |
| 2014-06-30 | $234k | 5.7k | 40.87 |
| 2014-03-31 | $220k | 5.7k | 38.43 |
| 2013-12-31 | $221k | 5.8k | 38.27 |
| 2013-06-30 | $205k | 5.9k | 34.89 |
More positions owned by Weybosset Research & Management
View all positions for Weybosset Research & Management